These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
363 related articles for article (PubMed ID: 26436700)
1. Recombinant rabies virus expressing dog GM-CSF is an efficacious oral rabies vaccine for dogs. Zhou M; Wang L; Zhou S; Wang Z; Ruan J; Tang L; Jia Z; Cui M; Zhao L; Fu ZF Oncotarget; 2015 Nov; 6(36):38504-16. PubMed ID: 26436700 [TBL] [Abstract][Full Text] [Related]
2. A Novel Rabies Vaccine Expressing CXCL13 Enhances Humoral Immunity by Recruiting both T Follicular Helper and Germinal Center B Cells. Wang Z; Li M; Zhou M; Zhang Y; Yang J; Cao Y; Wang K; Cui M; Chen H; Fu ZF; Zhao L J Virol; 2017 Feb; 91(3):. PubMed ID: 27852854 [TBL] [Abstract][Full Text] [Related]
3. Recombinant rabies viruses expressing GM-CSF or flagellin are effective vaccines for both intramuscular and oral immunizations. Zhou M; Zhang G; Ren G; Gnanadurai CW; Li Z; Chai Q; Yang Y; Leyson CM; Wu W; Cui M; Fu ZF PLoS One; 2013; 8(5):e63384. PubMed ID: 23700422 [TBL] [Abstract][Full Text] [Related]
4. Genetically modified rabies virus ERA strain is safe and induces long-lasting protective immune response in dogs after oral vaccination. Shuai L; Feng N; Wang X; Ge J; Wen Z; Chen W; Qin L; Xia X; Bu Z Antiviral Res; 2015 Sep; 121():9-15. PubMed ID: 26093157 [TBL] [Abstract][Full Text] [Related]
5. Intracerebral administration of recombinant rabies virus expressing GM-CSF prevents the development of rabies after infection with street virus. Wang H; Zhang G; Wen Y; Yang S; Xia X; Fu ZF PLoS One; 2011; 6(9):e25414. PubMed ID: 21980450 [TBL] [Abstract][Full Text] [Related]
6. Chimeric rabies virus-like particles containing membrane-anchored GM-CSF enhances the immune response against rabies virus. Kang H; Qi Y; Wang H; Zheng X; Gao Y; Li N; Yang S; Xia X Viruses; 2015 Mar; 7(3):1134-52. PubMed ID: 25768031 [TBL] [Abstract][Full Text] [Related]
7. High prevalence of antibodies against canine adenovirus (CAV) type 2 in domestic dog populations in South Africa precludes the use of CAV-based recombinant rabies vaccines. Wright N; Jackson FR; Niezgoda M; Ellison JA; Rupprecht CE; Nel LH Vaccine; 2013 Aug; 31(38):4177-82. PubMed ID: 23867013 [TBL] [Abstract][Full Text] [Related]
8. Rabies virus expressing dendritic cell-activating molecules enhances the innate and adaptive immune response to vaccination. Wen Y; Wang H; Wu H; Yang F; Tripp RA; Hogan RJ; Fu ZF J Virol; 2011 Feb; 85(4):1634-44. PubMed ID: 21106736 [TBL] [Abstract][Full Text] [Related]
9. A novel oral rabies vaccine enhances the immunogenicity through increasing dendritic cells activation and germinal center formation by expressing U-OMP19 in a mouse model. Zhao J; Zhang Y; Chen Y; Zhang J; Pei J; Cui M; Fu ZF; Zhao L; Zhou M Emerg Microbes Infect; 2021 Dec; 10(1):913-928. PubMed ID: 33905300 [TBL] [Abstract][Full Text] [Related]
10. Oral vaccination of dogs (Canis familiaris) with baits containing the recombinant rabies-canine adenovirus type-2 vaccine confers long-lasting immunity against rabies. Zhang S; Liu Y; Fooks AR; Zhang F; Hu R Vaccine; 2008 Jan; 26(3):345-50. PubMed ID: 18083277 [TBL] [Abstract][Full Text] [Related]
11. Recombinant rabies virus expressing the H protein of canine distemper virus protects dogs from the lethal distemper challenge. Wang FX; Zhang SQ; Zhu HW; Yang Y; Sun N; Tan B; Li ZG; Cheng SP; Fu ZF; Wen YJ Vet Microbiol; 2014 Dec; 174(3-4):362-371. PubMed ID: 25465178 [TBL] [Abstract][Full Text] [Related]
12. Codon optimization of G protein enhances rabies virus-induced humoral immunity. Pei J; Huang F; Wu Q; Luo Z; Zhang Y; Ruan J; Li Y; Zhou M; Fu Z; Zhao L J Gen Virol; 2019 Aug; 100(8):1222-1233. PubMed ID: 31259681 [TBL] [Abstract][Full Text] [Related]
13. Protective immune response of oral rabies vaccine in stray dogs, corsacs and steppe wolves after a single immunization. Zhugunissov K; Bulatov Y; Taranov D; Yershebulov Z; Koshemetov Z; Abduraimov Y; Kondibayeva Z; Samoltyrova A; Amanova Z; Khairullin B; Sansyzbay A Arch Virol; 2017 Nov; 162(11):3363-3370. PubMed ID: 28766059 [TBL] [Abstract][Full Text] [Related]
14. Adult dogs receiving a rabies booster dose with a recombinant adenovirus expressing rabies virus glycoprotein develop high titers of neutralizing antibodies. Tims T; Briggs DJ; Davis RD; Moore SM; Xiang Z; Ertl HC; Fu ZF Vaccine; 2000 Jun; 18(25):2804-7. PubMed ID: 10812222 [TBL] [Abstract][Full Text] [Related]
15. An optimized HMGB1 expressed by recombinant rabies virus enhances immunogenicity through activation of dendritic cells in mice. Wang Z; Liang Q; Zhang Y; Yang J; Li M; Wang K; Cui M; Chen H; Fu ZF; Zhao L; Zhou M Oncotarget; 2017 Oct; 8(48):83539-83554. PubMed ID: 29137362 [TBL] [Abstract][Full Text] [Related]
16. A Recombinant Rabies Virus Expressing Fms-like Tyrosine Kinase 3 Ligand (Flt3L) Induces Enhanced Immunogenicity in Mice. Zhang Y; Yang J; Li M; Cui M; Fu ZF; Zhao L; Zhou M Virol Sin; 2019 Dec; 34(6):662-672. PubMed ID: 31254272 [TBL] [Abstract][Full Text] [Related]
17. Protective antibody response of Balb/c mice to Bali rabies virus isolate propagated in BHK-21 cells. Astawa INM; Agustini NLP; Masa Tenaya IW; Aryawiguna IPGW J Vet Med Sci; 2018 Nov; 80(10):1596-1603. PubMed ID: 30210066 [TBL] [Abstract][Full Text] [Related]
18. A rabies virus vectored severe fever with thrombocytopenia syndrome (SFTS) bivalent candidate vaccine confers protective immune responses in mice. Tian L; Yan L; Zheng W; Lei X; Fu Q; Xue X; Wang X; Xia X; Zheng X Vet Microbiol; 2021 Jun; 257():109076. PubMed ID: 33957572 [TBL] [Abstract][Full Text] [Related]
19. Rapid clearance of SAG-2 rabies virus from dogs after oral vaccination. Orciari LA; Niezgoda M; Hanlon CA; Shaddock JH; Sanderlin DW; Yager PA; Rupprecht CE Vaccine; 2001 Aug; 19(31):4511-8. PubMed ID: 11483278 [TBL] [Abstract][Full Text] [Related]
20. Safety and serological response to a matrix gene-deleted rabies virus-based vaccine vector in dogs. McGettigan JP; David F; Figueiredo MD; Minke J; Mebatsion T; Schnell MJ Vaccine; 2014 Mar; 32(15):1716-9. PubMed ID: 24508037 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]